Low lean mass and chemotherapy toxicity risk in the elderly: the Fraction study protocol

BACKGROUND: Half of cancer cases occur in patients aged 70 and above. Majority of older patients are eligible for chemotherapy but evidence for treating this population is sparse and severe toxicities affect more than half of them. Determining prognostic biomarkers able to predict poor chemotherapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Steinmeyer, Zara, Gérard, Stéphane, Filleron, Thomas, Lozano, Stéphanie, Brechemier, Delphine, Abellan Van Kan, Gabor, Mourey, Loic, Cristol-Dalstein, Laurence, De Decker, Laure, Rolland, Yves, Balardy, Laurent
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6882112/
https://www.ncbi.nlm.nih.gov/pubmed/31775667
http://dx.doi.org/10.1186/s12885-019-6377-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6882112/
https://www.ncbi.nlm.nih.gov/pubmed/31775667
http://dx.doi.org/10.1186/s12885-019-6377-7

Ejemplares similares